RELMβ expression is restricted to goblet cells in the metaplastic epithelium of the distal esophagus in patients with BE, not in gastric-type mucosa or squamous epithelium, and is enhanced in dysplasia, which can be used as a potential biomarker for the accurate diagnosis of BE. This evidence concerns the gene RETNLB and Barrett esophagus.